Abstract:Cellulose-based absorbable hemostatic materials with the main component of carboxymethyl cellulose (CMC) have been widely developed. In order to improve the hemostatic performance of CMC, mesoporous bioglass nanoparticles (mBN)/CMC nanocomposite sponge was fabricated via lyophilization, and its morphology, structure and performance were characterized. The results reveal that mBN is spherical nanoparticles with an average diameter about 100 nm, extremely uniform particle size distribution and mesoporous structure inside, and its specific surface area is 852 m2/g. The introduction of mBN increases the pore size, porosity and negative surface charge density of the sponges. The whole blood clotting and plasma coagulation experiments indicate that mBN accelerates in vitro coagulation via the intrinsic pathway, does not significantly affect the extrinsic and common pathway. The cell experiment shows that mBN/CMC has better cell compatibility and promotes cell proliferation, compared with CMC. mBN/CMC is an promising absorbable hemostatic material with high performance for clinical application.